PDFF Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 10: | Line 10: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
<br />Note: The last meeting of this group was held on July 7, 2020; notes are posted after they are approved by the PDFF BC during the following t-con | |||
*[[Media:2020_05-07_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|May 7, 2020]] | *[[Media:2020_05-07_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|May 7, 2020]] | ||
*[[Media:2019_11-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 7, 2019]] | *[[Media:2019_11-07_QIBA_PDFF_Biomarker_Cmte_Call_Summary-FINAL.pdf|November 7, 2019]] | ||
Revision as of 15:51, 29 September 2020
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- RSNA Staff Support: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
Note: The last meeting of this group was held on July 7, 2020; notes are posted after they are approved by the PDFF BC during the following t-con
PDFF Biomarker Committee Call Summaries Archive